|
1
|
Kim HJ and Bae SC: Histone deacetylase
inhibitors: molecular mechanisms of action and clinical trials as
anti-cancer drugs. Am J Transl Res. 3:166–179. 2011.PubMed/NCBI
|
|
2
|
Grunstein M: Histone acetylation in
chromatin structure and transcription. Nature. 389:349–352. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miller CP, Singh MM, Rivera-Del Valle N,
Manton CA and Chandra J: Therapeutic strategies to enhance the
anti-cancer efficacy of histone deacetylase inhibitors. J Biomed
Biotechnol. 2011:5142612011. View Article : Google Scholar
|
|
4
|
Carew JS, Giles FJ and Nawrocki ST:
Histone deacetylase inhibitors: mechanisms of cell death and
promise in combination cancer therapy. Cancer Lett. 269:7–17. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spiegel S, Milstien S and Grant S:
Endogenous modulators and pharmacological inhibitors of histone
deacetylases in cancer therapy. Oncogene. 31:537–551. 2012.
|
|
6
|
Jung M: Inhibitors of histone deacetylase
as new anticancer agents. Curr Med Chem. 8:1505–1511. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Darkin-Rattray SJ, Gurnett AM, Myers RW,
et al: Apicidin: a novel antiprotozoal agent that inhibits parasite
histone deacetylase. Proc Natl Acad Sci USA. 93:13143–13147. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahn MY, Na YJ, Lee JW, Lee BM and Kim HS:
Apicidin induces apoptosis via Cytochrome c-mediated intrinsic
pathway in human ovarian cancer cells. Biomol Ther. 17:17–24. 2009.
View Article : Google Scholar
|
|
9
|
Im JY, Park H, Kang KW, Choi WS and Kim
HS: Modulation of cell cycles and apoptosis by apicidin in estrogen
receptor (ER)-positive and-negative human breast cancer cells. Chem
Biol Interact. 172:235–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahn MY, Lee J, Na YJ, Choi WS, Lee BM,
Kang KW and Kim HS: Mechanism of apicidin-induced cell cycle arrest
and apoptosis in Ishikawa human endometrial cancer cells. Chem Biol
Interact. 179:169–177. 2009. View Article : Google Scholar
|
|
11
|
Choi KH, Shim JH, Huong LD, Cho NP and Cho
SD: Inhibition of myeloid cell leukemia-1 by tolfenamic acid
induces apoptosis in mucoepidermoid carcinoma. Oral Dis.
17:469–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen S, Kepp O, Michaud M, et al:
Association and dissociation of autophagy, apoptosis and necrosis
by systematic chemical study. Oncogene. 30:4544–4556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Portt L, Norman G, Clapp C, Greenwood M
and Greenwood MT: Anti-apoptosis and cell survival: a review.
Biochim Biophys Acta. 1813:238–259. 2011. View Article : Google Scholar
|
|
14
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carew JS, Nawrocki ST and Cleveland JL:
Modulating autophagy for therapeutic benefit. Autophagy. 3:464–467.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rikiish H: Autophagic and apoptotic
effects of HDAC inhibitors on cancer cells. J Biomed Biotechnol.
2011:8302602011.
|
|
17
|
Amaravadi RK and Thompson DB: The roles of
therapy-induced autophagy and necrosis in cancer treatment. Clin
Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahn MY, Ahn SG and Yoon JH: Apicidin, a
histone deaceylase inhibitor, induces both apoptosis and autophagy
in human oral squamous carcinoma cells. Oral Oncol. 47:1032–1038.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee EJ, Kim J, Lee SA, Kim EJ, Chun YC,
Ryu MH and Yook JI: Characterization of newly established oral
cancer cell lines derived from six squamous cell carcinoma and two
mucoepidermoid carcinoma cells. Exp Mol Med. 37:379–390. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanematsu S, Uehara N, Miki H, Yoshizawa
K, Kawanaka A, Yuri T and Tsubura A: Autophagy inhibition enhances
sulforaphane-induced apoptosis in human breast cancer cells.
Anticancer Res. 30:3381–3390. 2010.PubMed/NCBI
|
|
21
|
Warnken M, Reitzenstein U, Sommer A, et
al: Characterization of proliferative effects of insulin, insulin
analogues and insulin-like growth factor-1 (IGF-1) in human lung
fibroblasts. Naunyn Schmiedebergs Arch Pharmacol. 382:511–524.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brunet A and Pouyssegur J: Mammalian MAP
kinase modules: how to transduce specific signals. Essays Biochem.
32:1–16. 1997.PubMed/NCBI
|
|
23
|
LeRoith D and Roberts CT Jr: The
insulin-like growth factor system and cancer. Cancer Lett.
195:127–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lalami Y, Vereecken P, Dequanter D,
Lothaire P and Awada A: Salivary gland carcinomas, paranasal sinus
cancers and melanoma of the head and neck: an update about rare but
challenging tumors. Curr Opin Oncol. 18:258–265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McHugh CH, Roberts DB, El-Naggar AK, et
al: Prognostic factors in mucoepidermoid carcinoma of the salivary
glands. Cancer. 118:3928–3936. 2012. View Article : Google Scholar
|
|
26
|
Kanzawa T, Germano IM, Komata T, Ito H,
Kond Y and Kondo S: Role of autophagy in temozolomide-induced
cytotoxicity for malignant glioma cells. Cell Death Differ.
11:448–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shao Y, Gao Z, Marks PA and Jiang X:
Apoptotic and autophagic cell death induced by histone deacetylase
inhibitors. Proc Natl Acad Sci USA. 101:18030–18035. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu YL, Yang PM, Shun CT, Wu MS, Weng JR
and Chem CC: Autophagy potentiates the anti-cancer effects of the
histone deacetylase inhibitors in hepatocellular carcinoma.
Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Amaravadi RK, Yu D, Lum JJ, et al:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boya P, Gonzalez-Polo RA, Casares N, et
al: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol.
25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan CH, Liang ZQ, Gu ZL, Yang YP, Reid P
and Qin ZH: Contributions of autophagic and apoptotic mechanisms to
CrTX-induced death of K562 cells. Toxicon. 47:521–530. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Luca A, Maiello MR, D’Alessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16:S17–27.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu C, Friday BB, Lai JP, McCollum A,
Atadja P, Roberts LR and Adjei AA: Abrogation of MAPK and Akt
signaling by AEE788 synergistically potentiates histone deacetylase
inhibitor-induced apoptosis through reactive oxygen species
generation. Clin Cancer Res. 13:1140–1148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarker D, Reid AH, Yap TA and de Bono JS:
Targeting the PI3K/AKT pathway for the treatment of prostate
cancer. Clin Cancer Res. 15:4799–4805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jang ER, Kim YJ, Myung SC, Kim W and Lee
CS: Different effect of protein kinase B/Akt and extracellular
signal-regulated kinase inhibition on trichostatin A-induced
apoptosis in epithelial ovarian carcinoma cell lines. Mol Cell
Biochem. 353:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nishioka C, Ikezoe T, Yang J, Koeffler HP
and Yokoyama A: Inhibition of MEK/ERK signaling synergistically
potentiates histone deacetylase inhibitor-induced growth arrest,
apoptosis and acetylation of histone H3 on p21waf1 promoter in
acute myelogenous leukemia cell. Leukemia. 22:1449–1452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kennedy SG, Wagner AJ, Conzen SD, Jordan
J, Bellacosa A, Tsichlis PN and Hay N: The PI 3-kinase/Akt
signaling pathway delivers an antiapoptotic signal. Genes Dev.
11:701–713. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Widmann C, Gibson S, Jarpe MB and Johnson
GL: Mitogen-activated protein kinase: conservation of a
three-kinase module from yeast to human. Physiol Rev. 79:143–180.
1999.PubMed/NCBI
|
|
39
|
Takeuchi H, Kanzawa T, Kondo Y and Kondo
S: Inhibition of platelet-derived growth factor signaling induces
autophagy in malignant glioma cells. Br J Cancer. 90:1069–1075.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mochizuki T, Asai A, Saito N, et al: Akt
protein kinase inhibits non-apoptotic programmed cell death induced
by ceramide. J Biol Chem. 277:2790–2797. 2002. View Article : Google Scholar
|
|
41
|
Ellington AA, Berhow MA and Singletary KW:
Inhibition of Akt signaling and enhanced ERK1/2 activity are
involved in induction of macroautophagy by triterpenoid B-group
soyasaponins in colon cancer cells. Carcinogenesis. 27:298–306.
2006. View Article : Google Scholar
|
|
42
|
Riedemann J and Macaulay VM: IGF1R
signalling and its inhibition. Endocr Relat Cancer. 13:S33–43.
2006. View Article : Google Scholar
|
|
43
|
Obara K, Ide F, Mishima K, Inoue H, Yamada
H, Hayashi Y and Saito I: Biological and oncogenic properties of
p53-deficient salivary gland epithelial cells with particular
emphasis on stromal-epithelial interactions in tumorigenesis.
Pathobiology. 73:261–270. 2006. View Article : Google Scholar
|
|
44
|
Mitsiades CS, Mitsiades NS, McMullan CJ,
et al: Transcriptional signature of histone deacetylase inhibition
in multiple myeloma: biological and clinical implications. Proc
Natl Acad Sci USA. 101:540–545. 2004. View Article : Google Scholar :
|
|
45
|
Kim SO, Choi BT, Choi IW, et al:
Anti-invasive activity of histone deacetylase inhibitors via the
induction of Egr-1 and the modulation of tight junction-related
proteins in human hepatocarcinoma cells. BMB Rep. 42:655–660. 2009.
View Article : Google Scholar : PubMed/NCBI
|
